UK cardiac monitoring company to float
This article was originally published in Clinica
Executive Summary
A UK company with FDA approval for its minimally-invasive cardiac output monitor is to float on the UK Alternative Investment Market (AIM). LiDCO, founded in 1991, gained FDA approval in 1999 for its lithium chloride solution measurement device.